MetLife, Inc.
MET
$69.51
-$6.40-8.43%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 20.49% | -23.22% | 10.72% | 1.38% | -16.35% |
| Total Other Revenue | 730.00% | -1,342.86% | -114.90% | -166.91% | -102.14% |
| Total Revenue | 21.93% | -28.80% | 7.43% | -0.11% | -22.34% |
| Cost of Revenue | 81.75% | -31.66% | 12.50% | -0.60% | -52.66% |
| Gross Profit | -31.25% | -12.75% | -12.52% | 1.60% | 80.45% |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.71% | 9.58% | 7.23% | 2.75% | -7.19% |
| Total Operating Expenses | 61.16% | -26.54% | 11.56% | 0.02% | -45.19% |
| Operating Income | -51.55% | -99.71% | -128.73% | -2.78% | 255.13% |
| Income Before Tax | -53.55% | -62.26% | -56.48% | -86.72% | 55.13% |
| Income Tax Expenses | -26.52% | -84.27% | -69.86% | -41.89% | 368.42% |
| Earnings from Continuing Operations | -61.16% | -57.58% | -55.41% | -94.81% | 30.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -133.33% | -20.00% | -20.00% | 0.00% | 50.00% |
| Net Income | -61.53% | -57.92% | -55.82% | -95.10% | 30.95% |
| EBIT | -51.55% | -99.71% | -128.73% | -2.78% | 255.13% |
| EBITDA | -45.72% | -96.10% | -120.74% | -2.67% | 217.08% |
| EPS Basic | -60.66% | -59.30% | -55.60% | -99.05% | 40.77% |
| Normalized Basic EPS | -51.16% | -60.52% | -54.65% | -86.27% | 66.62% |
| EPS Diluted | -60.73% | -59.12% | -55.56% | -99.04% | 40.73% |
| Normalized Diluted EPS | -51.10% | -60.50% | -54.60% | -86.26% | 66.76% |
| Average Basic Shares Outstanding | -5.81% | -5.58% | -5.41% | -5.88% | -6.43% |
| Average Diluted Shares Outstanding | -5.92% | -5.65% | -5.51% | -5.94% | -6.51% |
| Dividend Per Share | 4.00% | 4.00% | 4.00% | 4.17% | 4.17% |
| Payout Ratio | 1.58% | 1.35% | 1.23% | 19.20% | -0.26% |
